Autoimmunity against the ryanodine receptor in myasthenia gravis

Acta Physiologica Scandinavica

Volumn 171, Issue 3, 2001, Pages 379-384

  Skeie, G O ^a,b,c   Lunde, P K ^a,b   Sejersted, O M ^a,b   Mygland, A ^a,b   Aarli, J A ^a,b   Gilhus, N E ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Calcium release; Myasthenia gravis; Ryanodine binding; Ryanodine receptor antibodies; Thymoma

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CHOLINERGIC RECEPTOR; MUSCLE ANTIBODY; MUSCLE ANTIGEN; RYANODINE RECEPTOR;

ALLOSTERISM; AMINO TERMINAL SEQUENCE; AUTOIMMUNITY; CALCIUM TRANSPORT; CONFERENCE PAPER; HUMAN; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; THYMOMA;

ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYASTHENIA GRAVIS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THYMOMA; THYMUS NEOPLASMS;

EID: 0034852946     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2001.00841.x     Document Type: Conference Paper

References (53)

1. Muscle striation antibodies in myasthenia gravis: Diagnostic and functional significance
2. Late-onset MG
3. Accessory molecule expression in human thymomas and thymus
4. Broken dogma: Penetration of autoantibodies into living cells
5. Conformational state of the ryanodine receptor and functional effects of ryanodine on skeletal muscle
6. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum
7. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum
8. Structure and function of ryanodine receptors
9. Principles of paraneoplastic syndromes
10. Biochemistry and biophysics of excitation-contraction coupling
11. The ultrastructural localization of antigens for skeletal muscle antibodies in myasthenia gravis
12. Junctional feet and particles in the triads of fast-twitch muscle fibre
13. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma
14. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells
15. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from skeletal muscle
16. Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures
17. Striational antibodies in myasthenia gravis mainly react with ryanodine receptor
18. Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies
19. Purification and reconstitution of the calcium release channel from skeletal muscle
20. Structure of the calcium release channel of skeletal muscle sarcoplasmic reticulum and its regulation by calcium
21. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor
22. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor
23. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value
24. Myasthenia gravis
25. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors
26. 2+ release channel
27. The skeletal muscle binding site of antistriated muscle antibodies in myasthenia gravis: An electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments
28. Identification and characterization of three calmodulin binding sites of the skeletal muscle ryanodine receptor
29. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmatic reticulum
30. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma
31. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma
32. Anti-cardiac ryanodine receptor antibodies in thymoma associated myasthenia gravis
33. Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis
34. Thymomas express epitopes shared by the ryanodine receptor
35. Rapid improvement of myasthenia gravis after plasma exchange
36. Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis
37. Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis
38. Microscopic thymoma: Histological evidence of multifocal cortical and medullary origin
39. FcγRIIA and FcγRIIIB polymorphisms in myasthenia gravis
40. Ryanodine receptor antibodies are associated with severe myasthenia gravis
41. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes
42. 3H]-ryanodine to sarcoplasmic reticulum
43. Tumor necrosis factor (TNF)-α and TNF-β polymorphisms in myasthenia gravis
44. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis
45. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor
46. Exitation- contraction uncoupling in mice lacking functional skeletal muscle ryanodine-receptor gene
47. Region of the skeletal muscle dihydropyridine receptor critical for exitation-contraction coupling
48. 2+release
49. Epitope spreading
50. Myasthenic and nonmyasthenic thymoma: An expansion of a minor cortical epithelial cell subser?
51. Myasthenia gravis
52. 2+ release channel
53. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum